Hideyuki Hashiba

A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)

Hidenori Mizugaki, Noboru Yamamoto, Hiroshi Nokihara et al. · Cancer Chemotherapy and Pharmacology · 2015 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors

Tadaaki Nishikawa, Koji Matsumoto, Kenji Tamura et al. · Cancer Science · 2017 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer

Shin Nishio, Munetaka Takekuma, Satoshi Takeuchi et al. · Cancer Science · 2017 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial

Carol Aghajanian, Elizabeth M. Swisher, Aikou Okamoto et al. · Gynecologic Oncology · 2021 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +16